Introduction: Some abnormal electrocardiographic findings were independently associated with increased mortality in patients admitted for COVID-19; however, no studies have focussed on the prognosis impact of the interatrial block (IAB) in this clinical setting. The aim of our study was to assess the prevalence and clinical implications of IAB, both partial and advanced, in hospitalized COVID-19 patients. Materials: We retrospectively evaluated 300 consecutive COVID-19 patients (63.22 ± 15.16 years; 70% males) admitted to eight Italian Hospitals from February 2020 to April 2020 who underwent twelve lead electrocardiographic recording at admission. The study population has been dichotomized into two groups according to the evidence of IAB at admission, both partial and advanced. The differences in terms of ARDS in need of intubation, in-hospital mortality and thromboembolic events (a composite of myocardial infarction, stroke and transient ischaemic attack) have been evaluated. Results: The presence of IAB was noticed in 64 patients (21%). In the adjusted logistic regression model, the partial interatrial block was found to be an independent predictor of ARDS in need of intubation (HR: 1.92; p:.04) and in-hospital mortality (HR: 2.65; p:.02); moreover, the advanced interatrial block was an independent predictor of thrombotic events (HR: 7.14; p <.001). Conclusions: Among COVID-19 patients hospitalized in medical wards, the presence of interatrial block is more frequent than in the general population and it might be useful as an early predictor for increased risk of incident thrombotic events, ARDS in need of intubation and in-hospital mortality.

The prognostic role of interatrial block among COVID-19 patients hospitalized in medicine wards / Russo, V.; Albani, S.; Caturano, A.; Weisz, S. H.; Parisi, V.; Conte, M.; Zaccaro, L.; D'Andrea, A.; Al-Turky, A.; Marchel, M.; Marano, M.; Sasso, F. C.; Attena, E.. - In: EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. - ISSN 0014-2972. - 52:8(2022). [10.1111/eci.13781]

The prognostic role of interatrial block among COVID-19 patients hospitalized in medicine wards

Caturano A.;Parisi V.;
2022

Abstract

Introduction: Some abnormal electrocardiographic findings were independently associated with increased mortality in patients admitted for COVID-19; however, no studies have focussed on the prognosis impact of the interatrial block (IAB) in this clinical setting. The aim of our study was to assess the prevalence and clinical implications of IAB, both partial and advanced, in hospitalized COVID-19 patients. Materials: We retrospectively evaluated 300 consecutive COVID-19 patients (63.22 ± 15.16 years; 70% males) admitted to eight Italian Hospitals from February 2020 to April 2020 who underwent twelve lead electrocardiographic recording at admission. The study population has been dichotomized into two groups according to the evidence of IAB at admission, both partial and advanced. The differences in terms of ARDS in need of intubation, in-hospital mortality and thromboembolic events (a composite of myocardial infarction, stroke and transient ischaemic attack) have been evaluated. Results: The presence of IAB was noticed in 64 patients (21%). In the adjusted logistic regression model, the partial interatrial block was found to be an independent predictor of ARDS in need of intubation (HR: 1.92; p:.04) and in-hospital mortality (HR: 2.65; p:.02); moreover, the advanced interatrial block was an independent predictor of thrombotic events (HR: 7.14; p <.001). Conclusions: Among COVID-19 patients hospitalized in medical wards, the presence of interatrial block is more frequent than in the general population and it might be useful as an early predictor for increased risk of incident thrombotic events, ARDS in need of intubation and in-hospital mortality.
2022
The prognostic role of interatrial block among COVID-19 patients hospitalized in medicine wards / Russo, V.; Albani, S.; Caturano, A.; Weisz, S. H.; Parisi, V.; Conte, M.; Zaccaro, L.; D'Andrea, A.; Al-Turky, A.; Marchel, M.; Marano, M.; Sasso, F. C.; Attena, E.. - In: EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. - ISSN 0014-2972. - 52:8(2022). [10.1111/eci.13781]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/921240
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 2
  • ???jsp.display-item.citation.isi??? ND
social impact